Andrew Davis Net Worth & Insider Trades
Andrew Davis - SVP, Ironwood Pharmaceuticals Inc
What is Andrew Davis's Net Worth?
The current estimated net worth of Ironwood Pharmaceuticals Inc's SVP, Andrew Davis, is estimated to be about $1.8M . Andrew Davis owns about 219,327 units of Ironwood Pharmaceuticals Inc common stock. In the last year at Ironwood Pharmaceuticals Inc, Andrew Davis has sold an estimated value of $142.94K worth.
What is Andrew Davis's Past Insider Trading?
Andrew Davis's largest sale order was 6,305 units , worth over $63.81K on May 24, 2023. In total, Andrew Davis has made about 4 transactions over a year of their time at Ironwood Pharmaceuticals Inc. Andrew Davis usually trades in March, with the busiest year in 2023.
Andrew Davis
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Andrew Davis's' Mailing Address?
- Mailing address is 100 Summer Street Suite 2300 Boston MA 02110 MA
Ironwood Pharmaceuticals Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Mark Mallon* | 2020 | $801,173 | - | $5,423,731 | - | $585,169 | $11,040 | $6,821,113 |
| Mark Mallon* | 2019 | $750,000 | $880,000 | $3,692,810 | $3,804,331 | $797,063 | $144,596 | $10,068,800 |
| Mark Mallon* | 2018 | - | - | - | - | - | - | - |
| Gina Consylman | 2020 | $512,751 | - | $1,676,402 | - | $264,652 | $11,040 | $2,464,845 |
| Gina Consylman | 2019 | $480,000 | $250,000 | $1,467,731 | $888,546 | $358,800 | $8,502 | $3,453,579 |
| Gina Consylman | 2018 | $415,000 | - | $782,385 | $501,764 | $207,500 | $8,040 | $1,914,688 |
| Thomas McCourt* | 2020 | $576,120 | - | $2,465,327 | - | $357,409 | $11,040 | $3,409,896 |
| Thomas McCourt* | 2019 | $511,250 | - | $1,760,143 | $2,370,159 | $454,272 | $8,502 | $5,104,327 |
| Thomas McCourt* | 2018 | $465,000 | - | $549,641 | $869,479 | $232,500 | $34,002 | $2,150,622 |
| Jason Rickard | 2020 | $473,314 | - | $1,479,191 | - | $258,338 | $11,040 | $2,221,883 |
| Jason Rickard | 2019 | - | - | - | - | - | - | - |
| Jason Rickard | 2018 | - | - | - | - | - | - | - |
| Michael Shetzline, M.D., Ph.D. | 2020 | $464,681 | $100,000 | $1,121,001 | - | $194,558 | $11,040 | $1,891,310 |
| Michael Shetzline, M.D., Ph.D. | 2019 | - | - | - | - | - | - | - |
| Michael Shetzline, M.D., Ph.D. | 2018 | - | - | - | - | - | - | - |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1446847/000104746921001006/a2243150zdef14a.htm
What are Ironwood Pharmaceuticals Inc's Past Insider Trades?
Ironwood Pharmaceuticals Inc's most recent insider trade came on June 1, 2023 by Thomas McCourt who sold 26,632 units worth $284.96K . In the last 13 years, insiders at Ironwood Pharmaceuticals Inc have sold an estimated value of $119.28M and bought an estimated value of $42.1M worth of shares. Insider trading is most common in March, with the busiest year in 2019. The most active traders at the company are Mark Currie, Director, Thomas McCourt, Chief Executive Officer, and Bryan E Roberts, Director .
IRONWOOD PHARMACEUTICALS INC Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||